Recently, the prostate health index has emerged as a commercially available test that combines total PSA, %fPSA, and the p2PSA isoform into a single score with superior specificity for clinically significant or aggressive PCa [49]. The gene discussed is KLK3; the disease is posterior cortical atrophy.